Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Tissue Regenix bolsters board with Consort chief

Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry
Tissue Regenix bolsters board with Consort chief
Tissue Regenix has patented a cell-washing technology

Regenerative med-tech Tissue Regenix (LON:TRX) has appointed the chief executive of Consort Medical to its board as a non-executive.

Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry including seven years at Celltech where he played a key role in the acquisitions of Chiroscience, Medeva and OGS.

John Samuel, Tissue Regenix’s chairman, he was very pleased Glenn was joining the business.

“He has excellent experience in the medical devices market.”

Tissue Regenix has patented a cell-washing technology that it is using to pioneer replacement body parts including skin, knee cartilages, ligaments and heart valves.

PhilW.jpg
Why Invest In Tissue Regenix Group PLC? Read More Here

Register here to be notified of future TRX Company articles
View full TRX profile

Tissue Regenix Group PLC Timeline

Related Articles

antibiotic.jpg
March 02 2016
In all 1,200 patients will take part in the global trials run by Motif’s partner Covance.
Pollen2.jpg
July 13 2016
Updating investors, the company said turnover will be around £48.5mln, representing a rise of 12%, or 19% once the figure is adjusted for currency movements.
Astrazeneca1_5704c41deea83.jpg
April 06 2016
Researchers administered Atu027 to patients with pancreatic cancer, one of the hardest strains of the disease to treat.

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.